SCHEMBL16429545

SCHEMBL16429545

CCOC(=O)c1sc2c(sc3c4sc(C(=O)OCC)c(-c5ccccc5)c4sc23)c1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
HPGD P15428 8/20 0.55
MAPT P10636 7/20 0.55
RAB9A P51151 4/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
HSD17B10 Q99714 3/20 0.55
KDM4E B2RXH2 3/20 0.55
NPC1 O15118 3/20 0.55
CDC7 O00311 3/20 0.55
DBF4 Q9UBU7 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
TRPM8 Q7Z2W7 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
GRM6 O15303 3/20 0.53
GAA P10253 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
LMNA P02545 2/20 0.52
PDE4A P27815 2/20 0.52
PDE4B Q07343 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17808357 0.92 ALDH1A1 (0.48) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL16429651 0.85 ALDH1A1 (0.49) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL20015818 0.82 MAPT (0.59) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL10487739 0.82 CDC7 (0.58) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL17813869 0.80 TSHR (0.46) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL25205779 0.79 HPGD (0.46) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL11307879 0.78 ALDH1A1 (0.78) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL20016050 0.78 MAPT (0.62) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL20010798 0.77 KDM4E (0.54) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL21741107 0.75 MAPT (0.58) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9876182-B2 Thieno-containing compounds and processes and uses thereof UNIVERSITY OF OREGON (US) 2018-01-23 US disclosed
US-9876182-B2 Thieno-containing compounds and processes and uses thereof UNIVERSITY OF OREGON (US) 2018-01-23 US disclosed
US-20160164011-A1 THIENO-CONTAINING COMPOUNDS AND PROCESSES AND USES THEREOF UNIVERSITY OF OREGON (US) 2016-06-09 US disclosed
US-20160164011-A1 THIENO-CONTAINING COMPOUNDS AND PROCESSES AND USES THEREOF UNIVERSITY OF OREGON (US) 2016-06-09 US disclosed
WO-2015013656-A2 THIENO-CONTAINING COMPOUNDS AND PROCESSES AND USES THEREOF UNIVERSITY OF OREGON (US) 2015-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160164011-A1 THIENO-CONTAINING COMPOUNDS AND PROCESSES AND USES THEREOF TERT, TES, DDT ALDH1A1 245/4885HPGD 313/4885MAPT 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.